[The role of nanotechnology in creating novel antitumor agents]
- PMID: 22238935
[The role of nanotechnology in creating novel antitumor agents]
Abstract
Nanobiotechnology, defined as an arm of a nano-system is a rapidly developing area of medicine. Nanomaterials ranging from 1 to 1000 nm in size offer unique advantages of interaction with biological systems on the molecular level. Nanobiotechnologies can be used in definition, diagnosis and treatment of cancer thus leading to the new development of a new discipline--nanooncology. The potential of nanoparticles to be used in in-vivo tumor visualization, biomolecular profiling of tumor growth factors and targeted drug delivery is being studied. These methods stemming from nanotechnology may soon find a broad application in oncology.
Similar articles
-
Treatment innovations for metastatic breast cancer: nanoparticle albumin-bound (NAB) technology targeted to tumors.Crit Rev Oncol Hematol. 2014 Jan;89(1):62-72. doi: 10.1016/j.critrevonc.2013.08.001. Epub 2013 Aug 21. Crit Rev Oncol Hematol. 2014. PMID: 24071503 Review.
-
Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.Anticancer Res. 2017 Nov;37(11):5975-5981. doi: 10.21873/anticanres.12044. Anticancer Res. 2017. PMID: 29061776 Review.
-
Emerging use of nanoparticles in diagnosis and treatment of breast cancer.Lancet Oncol. 2006 Aug;7(8):657-67. doi: 10.1016/S1470-2045(06)70793-8. Lancet Oncol. 2006. PMID: 16887483 Review.
-
Recent developments in taxane drug delivery.Curr Drug Deliv. 2008 Jan;5(1):42-54. doi: 10.2174/156720108783331005. Curr Drug Deliv. 2008. PMID: 18220550 Review.
-
Nanotechnology platforms and physiological challenges for cancer therapeutics.Nanomedicine. 2007 Jun;3(2):103-10. doi: 10.1016/j.nano.2006.12.002. Epub 2007 Apr 17. Nanomedicine. 2007. PMID: 17442621 Review.
MeSH terms
Substances
LinkOut - more resources
Medical